Skip to main content
. Author manuscript; available in PMC: 2018 Nov 13.
Published in final edited form as: Atten Defic Hyperact Disord. 2017 Feb 7;9(2):121–127. doi: 10.1007/s12402-017-0219-8

Table 1.

Results for attention-deficit/hyperactivity disorder candidate single nucleotide polymorphisms in Parkinson’s disease meta-analysis

Gene SNP Effect allele/other allele Allele frequency P value Effect Het p
CDH13 rs6565113 T/G 0.53 0.20  0.032 0.76
CDH13 rs11646411 C/G 0.88 0.92  0.004 0.73
CDH13 rs7187223 A/G 0.96 0.65 −0.028 0.58
DRD4 rs1800955 T/C 0.65 0.70 −0.0115 0.63
HTR1B rs6296 C/G 0.74 0.16  0.0405 0.45
SLC6A2 (NET1) rs3785143 T/C 0.091 0.958  0.0023 0.075
SLC6A3 (DAT1) rs27072 T/C 0.17 0.35 −0.031 0.33
SNAP25 rs3746544 T/G 0.65 0.97  9.00E-04 0.17
TPH2 rs1843809 T/G 0.85 0.037* −0.071 0.77
*

Nominal significant; the shown p values are not corrected for multiple testing; Het p = heterogeneity p value; data derived from the PD meta-analysis (Nalls et al. 2011)